# FDA 483 - Integris Bioservices LLC - October 20, 2023

Source: https://www.globalkeysolutions.net/records/483/integris-bioservices-llc/79d4824a-8abe-4e6d-800d-57c730adcd40

> FDA 483 for Integris Bioservices LLC on October 20, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Integris Bioservices LLC
- Inspection Date: 2023-10-20
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/integris-bioservices-llc/dc719459-dc33-4404-9f81-735571168813)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/integris-bioservices-llc/114bc71a-2394-42ca-b202-1d48aab68a9f)
- [483 - 2025-08-29](https://www.globalkeysolutions.net/records/483/integris-bioservices-llc/7dedc35a-37f3-4310-a899-890609adb206)

## Related Officers

- [Yiyue C. Zhang](https://www.globalkeysolutions.net/people/yiyue-c-zhang/bb9e053e-ff20-4724-b4dc-1ee2e8f23833)

Company: https://www.globalkeysolutions.net/companies/integris-bioservices-llc/1f2e0885-338c-49d4-9afd-14924079d628

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd